Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a Consumer or other non HCP.  A 65-year-old male patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 18Sep2023 as dose 1, single (Lot number: HH7595) at the age of 65 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2;BNT162b2 omi ba.4-5 ({vaccine_brand=Pfizer /BioNTech, vaccine_brand_unknown=False,, vaccine_administration_date=26Apr2023,, vaccine_lot_number=GU3270,, vaccine_lot_unknown=False,, vaccine_dose_number=6,, vaccine_dose_number_unknown=False,, vaccine_location=Left arm},), administration date: 26Apr2023, when the patient was 64-year-old, for Covid-19 Immunization; BNT162b2;BNT162b2 omi ba.4-5 ({vaccine_brand=Pfizer /BioNTech, vaccine_brand_unknown=False,, vaccine_administration_date=07Sep2022,, vaccine_lot_number=GH9694,, vaccine_lot_unknown=False,, vaccine_dose_number=5,, vaccine_dose_number_unknown=False,, vaccine_location=Left arm},), administration date: 07Sep2022, when the patient was 64-year-old, for Covid-19 Immunization; BNT162b2 (vaccine_brand=Pfizer /BioNTech, vaccine_brand_unknown=False,, vaccine_administration_date=02Apr2022,, vaccine_lot_number=FK9893,, vaccine_lot_unknown=False,, vaccine_dose_number=4,, vaccine_dose_number_unknown=False,, vaccine_location=Left arm},), administration date: 02Apr2022, when the patient was 63-year-old, for Covid-19 Immunization; BNT162b2 (vaccine_brand=Pfizer /BioNTech, vaccine_brand_unknown=False,, vaccine_administration_date=17Aug2021,, vaccine_lot_number=FD8448,, vaccine_lot_unknown=False,, vaccine_dose_number=3,, vaccine_dose_number_unknown=False,, vaccine_location=Left arm}), administration date: 17Aug2021, when the patient was 63-year-old, for Covid-19 Immunization; BNT162b2 (vaccine_brand=Pfizer /BioNTech, vaccine_brand_unknown=False,, vaccine_administration_date=11Mar2021,, vaccine_lot_number=EN6206,, vaccine_lot_unknown=False,, vaccine_dose_number=2,, vaccine_dose_number_unknown=False,, vaccine_location=Left arm},), administration date: 11Mar2021, when the patient was 62-year-old, for Covid-19 Immunization; BNT162b2 ({vaccine_brand=Pfizer /BioNTech, vaccine_brand_unknown=False,, vaccine_administration_date=18Feb2021,, vaccine_lot_number=EN6200,, vaccine_lot_unknown=False,, vaccine_dose_number=1,, vaccine_dose_number_unknown=False,, vaccine_location=Left arm}]), administration date: 18Feb2021, when the patient was 62-year-old, for Covid-19 Immunization. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Dec2023, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (24Dec2023) Positive, notes: Tested positive two days after completing course of Paxlovid. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: Patient received treatment with Paxlovid from 17Dec2023 to 22Dec2023 for COVID-19.